NEW YORK (GenomeWeb) – NeoGenomics today reported a 3 percent year-over-year rise in revenues for the first quarter, while clinical testing revenues grew 4 percent.

For the three months ended March 31, the Fort Myers, Florida-based cancer genetic testing firm recorded $61.7 million in total revenues, slightly above the consensus Wall Street estimate of $61.4 million, and up from $59.7 million in the year-ago period.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.